Go to Top

In the Spotlight

Daniel F. Feezell, Ph.D.

Daniel F. Feezell, Ph.D. Assistant Professor, Department of Electrical & Computer Engineering The University of New Mexico Dr. Feezell has disclosed four inventions to STC, received three UNM-affiliated issued U. S. patents, and has three pending U. S. patent applications for his semiconductor and LED technologies. Present research efforts in nanoscale FETs (field effect transistors) technologies are focusing on alternative methods of increasing current control (specifically decreasing current leakage), device …Read More

Natalie L. Adolphi, Ph.D.

Natalie L. Adolphi, Ph.D. Associate Professor, Department of Biochemistry & Molecular Biology Research Director, Center for Forensic Imaging Health Sciences Center The University of New Mexico Dr.  Adophi has disclosed three inventions to STC, received one UNM-affiliated issued U. S. patent, and has one pending U. S. patent application for her viscosity measurement technology. Dr. Adolphi’s technology for measuring viscosity in a fluid (a fluid’s internal resistance to flow) uses …Read More

Mohamed S. El-Genk, Ph.D.

Mohamed S. El-Genk, Ph.D. Regents’ Professor, Departments of Nuclear Engineering, Mechanical Engineering, and Chemical & Biological Engineering Founding Director, Institute of Space and Nuclear Power Studies The University of New Mexico Dr. El-Genk has disclosed 11 inventions to STC, received three UNM-affiliated issued U. S. patents, and has four pending U. S. patent applications for his nuclear power and reactor technologies. The generation-IV, helium-cooled, very high-temperature reactor (VHTR) concept is …Read More

Todd A. Thompson, Ph.D.

Todd A. Thompson, Ph.D. Associate Professor, Department of Pharmaceutical Sciences Health Sciences Center The University of New Mexico Dr. Thompson has disclosed three inventions to STC and received two UNM-affiliated issued U. S. patents for his cancer treatment technologies. Cancer treatment technologies developed by Dr. Thompson include methods and compounds that modulate autophagy (i.e., recycling of cellular components) in cancer cells.  The screening assay he developed, using high-throughput flow cytometry, …Read More

Wolfgang G. Rudolph, Ph.D.

Wolfgang G. Rudolph, Ph.D. Regents’ Professor and Chair, Department of Physics & Astronomy The University of New Mexico Dr.  Rudolph has disclosed 9 inventions to STC, received three UNM-affiliated issued U. S. patents, and has one pending U. S. patent application for his  microscopy and laser technologies. His gas-filled laser technology is the first optically pumped gas laser (OPGL) on population inversion in a hollow core photonic crystal fiber (HC-PCF). …Read More

Wadih Arap, M.D., Ph.D.

Wadih Arap, M.D., Ph.D. Professor, Department of Internal Medicine Chief, Division of Hematology/Oncology Deputy Director, UNM Cancer Center Health Sciences Center The University of New Mexico Dr.  Arap has disclosed five inventions to STC and has three UNM-affiliated pending patent applications for his new therapeutic drugs to treat prostate, lung and breast cancers. In 2014, the National Cancer Institute estimated that there will be 233,000 new cases of prostate cancer …Read More

Gabriel P. López, Ph.D.

Gabriel P. López, Ph.D. Vice President for Research Professor, Department of Chemical & Biological Engineering Founding Director and Member, Center for Biomedical Engineering The University of New Mexico Eta Diagnostics, Inc. (STC start-up) Pucara Engineering and Logistics, LLC (STC start-up) ieCrowd (STC start-up being spun out) Dr.  López has disclosed 53 inventions to STC, received 34 UNM-affiliated issued U. S. patents, has one pending patent application, one license agreement with …Read More

Walker R. Wharton, Ph.D.

Walker R. Wharton, Ph.D. Research Professor, Department of Pathology Health Sciences Center The University of New Mexico Dr.  Wharton has disclosed eight inventions to STC, received one UNM-affiliated issued U. S. patent, has three pending patent applications for his protocell technologies, and has one license agreement with Oncothyreon for his protocell technology. Drug delivery is one of the most important areas in nanomedicine, which utilizes nanoscale materials and principles as …Read More

Mahmoud R. Taha, Ph.D.

Mahmoud R. Taha, Ph.D. Professor, Regents’ Lecturer and Chair, Department of Civil Engineering Cross Appointments: Department of Mechanical Engineering, Department of Electrical & Computer Engineering, and Center for Biomedical Engineering The University of New Mexico Dr.  Taha has disclosed 18 inventions to STC, received two UNM-affiliated issued U. S. patents, and has seven pending patent applications for his polymer concretes, nanocomposites and composite technologies. Dr. Taha’s polymer concrete technology combines …Read More

Bridget S. Wilson, Ph.D.

Bridget S. Wilson, Ph.D. Professor, Department of Pathology Director, New Mexico Center for Spatiotemporal Modeling of Cell Signaling Health Sciences Center The University of New Mexico Dr. Wilson has disclosed four inventions and has two pending patent applications for her recombinant hypoallergens technology and her therapeutic antibodies technology for targeting pre-BCR B cell precursor in acute lymphoblastic leukemia (pre-B ALL). Dr. Wilson’s recombinant hypoallergens technology uses state-of-the art imaging and …Read More